Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Immedica Pharma AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 98,608 Less Arrow 81,600 Less Arrow 54,778
Financial expenses 11,009 Less Arrow 6,424 More Arrow 6,935
Earnings before taxes -9,042 More Arrow 7,532 Less Arrow 2,930
EBITDA 11,701 More Arrow 20,994 Less Arrow 16,787
Total assets 210,174 Less Arrow 200,600 Less Arrow 138,205
Current assets 65,095 Less Arrow 52,894 Less Arrow 31,041
Current liabilities 34,584 Less Arrow 30,258 Less Arrow 15,229
Equity capital 75,456 Less Arrow 74,816 Less Arrow 59,241
- share capital 4 More Arrow 5 Less Arrow 4
Employees (average) 69 More Arrow 88 Less Arrow 69

Financial ratios

Fiscal year 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 35.9% More Arrow 37.3% More Arrow 42.9%
Turnover per employee 1,429 Less Arrow 927 Less Arrow 794
Profit as a percentage of turnover -9.2% More Arrow 9.2% Less Arrow 5.3%
Return on assets (ROA) 0.9% More Arrow 7.0% More Arrow 7.1%
Current ratio 188.2% Less Arrow 174.8% More Arrow 203.8%
Return on equity (ROE) -12.0% More Arrow 10.1% Less Arrow 4.9%
Change turnover
Change turnover % 49% Less Arrow 23%
Chg. No. of employees
Chg. No. of employees % 28% More Arrow 33%

Total value of public sale

Fiscal year 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.